Annual EBITDA
-$81.00 M
-$57.77 M-248.67%
31 December 2023
Summary:
NKGen Biotech Common Stock annual earnings before interest, taxes, depreciation & amortization is currently -$81.00 million, with the most recent change of -$57.77 million (-248.67%) on 31 December 2023. NKGN annual EBITDA is now -291.28% below its all-time high of -$20.70 million, reached on 31 December 2021.NKGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$15.12 M
-$11.13 M-279.11%
30 June 2024
Summary:
NKGen Biotech Common Stock quarterly earnings before interest, taxes, depreciation & amortization is currently -$15.12 million, with the most recent change of -$11.13 million (-279.11%) on 30 June 2024. Over the past year, it has increased by +$17.55 million (+53.73%). NKGN quarterly EBITDA is now -279.11% below its all-time high of -$3.99 million, reached on 31 March 2024.NKGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$84.63 M
-$7.63 M-9.90%
30 June 2024
Summary:
NKGen Biotech Common Stock TTM earnings before interest, taxes, depreciation & amortization is currently -$84.63 million, with the most recent change of -$7.63 million (-9.90%) on 30 June 2024. Over the past year, it has dropped by -$30.47 million (-56.27%). NKGN TTM EBITDA is now -1297.21% below its all-time high of -$6.06 million, reached on 01 September 2022.NKGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -248.7% | +53.7% | -56.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
NKGN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -291.3% | at low | -279.1% | +54.0% | -1297.2% | at low |
| 5 y | 5 years | -291.3% | at low | -279.1% | +54.0% | -1297.2% | at low |
| alltime | all time | -291.3% | at low | -279.1% | +54.0% | -1297.2% | at low |
NKGen Biotech Common Stock EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$15.12 M(+279.1%) | -$84.63 M(+9.9%) |
| Mar 2024 | - | -$3.99 M(-87.9%) | -$77.00 M(-4.9%) |
| Dec 2023 | -$81.00 M | -$32.86 M(+0.6%) | -$81.00 M(+49.6%) |
| Sept 2023 | - | -$32.67 M(+336.2%) | -$54.16 M(+96.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$7.49 M(-6.2%) | -$27.55 M(+37.3%) |
| Mar 2023 | - | -$7.98 M(+32.6%) | -$20.06 M(+66.1%) |
| Dec 2022 | -$23.23 M(+12.2%) | -$6.02 M(-0.6%) | -$12.08 M(+99.4%) |
| Sept 2022 | - | -$6.06 M | -$6.06 M |
| Dec 2021 | -$20.70 M | - | - |
FAQ
- What is NKGen Biotech Common Stock annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock annual EBITDA year-on-year change?
- What is NKGen Biotech Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock quarterly EBITDA year-on-year change?
- What is NKGen Biotech Common Stock TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock TTM EBITDA year-on-year change?
What is NKGen Biotech Common Stock annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NKGN is -$81.00 M
What is the all time high annual EBITDA for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high annual earnings before interest, taxes, depreciation & amortization is -$20.70 M
What is NKGen Biotech Common Stock annual EBITDA year-on-year change?
Over the past year, NKGN annual earnings before interest, taxes, depreciation & amortization has changed by -$57.77 M (-248.67%)
What is NKGen Biotech Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NKGN is -$15.12 M
What is the all time high quarterly EBITDA for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$3.99 M
What is NKGen Biotech Common Stock quarterly EBITDA year-on-year change?
Over the past year, NKGN quarterly earnings before interest, taxes, depreciation & amortization has changed by +$17.55 M (+53.73%)
What is NKGen Biotech Common Stock TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NKGN is -$84.63 M
What is the all time high TTM EBITDA for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6.06 M
What is NKGen Biotech Common Stock TTM EBITDA year-on-year change?
Over the past year, NKGN TTM earnings before interest, taxes, depreciation & amortization has changed by -$30.47 M (-56.27%)